Variables | Group A (n=15) | Group B (n=15) | P value |
Age at surgery mean (range), years | 4.0 (1.2–7.5) | 4.1 (0.8–12.8) | 0.92 |
Age at diagnosis (months) | |||
<18 | 2 | 5 | 0.15 |
>18 | 13 | 10 | |
Male:female | 4:11 | 11:4 | 0.01 |
Stage | |||
3 | 4 | 0 | 0.1 |
4 | 11 | 15 | |
Risk group | |||
IR | 4 | 5 | 0.29 |
HR | 11 | 10 | |
MYCN status | |||
Amplification | 1 | 2 | 0.39 |
No amplification | 14 | 13 | |
Other metastases | |||
Bone | 9 | 6 | 0.55 |
Bone marrow | 9 | 5 | |
Lymph nodes | 6 | 8 | |
Preoperative chemotherapy | |||
Median (range) cycles | 4 (2–11) | 5 (2–10) | 0.94 |
HR, high risk; IR, intermediate risk.